KATELIN ELENTERIO: Open Payments
NPI 1427612050 · PORT JEFFERSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,172 in 105 payments from 17 companies in 2025. Trend: 2023 $2,115 · 2024 $1,983 · 2025 $2,172
Food & beverage: $2,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $541 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $230 |
| Lilly USA, LLC | 9 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| GENZYME CORPORATION | 8 | $164 |
| PFIZER INC. | 6 | $143 |
| ARGENX US, INC. | 1 | $132 |
| Phathom Pharmaceuticals, Inc. | 7 | $125 |
| Ardelyx, Inc. | 4 | $101 |
| QOL Medical, LLC | 3 | $100 |
Products named: RINVOQ, XIFAXAN, OMVOH, DUPIXENT, ENTYVIO, VYVGART, VOQUEZNA, LINZESS.
Industry payments across NY — which companies pay providers there.
